Literature DB >> 28946130

Bile acid transporter mediated endocytosis of oral bile acid conjugated nanocomplex.

Jooho Park1, Jeong Uk Choi2, Kwangmeyung Kim3, Youngro Byun4.   

Abstract

The development of highly funtional and orally available nanoparticles is the ultimate goal in nanoparticle delivery. Various functional nanoparticles have been studied to that end but there has yet to be an oral nanoparticle that can be successfully applied. Here, we describe for the first time a novel bile acid conjugated nanoparticle that can be selectively absorbed by bile acid transporters in the small intestine. The bile acid conjugate nanoparticles that were first treated with enterocytes were successfully attached to the cell surface and then internalized inside the cells. We show that bile acid based interaction between a nanoparticle and its transporter induces its endocytosis and cellular uptake. This feature of cellular activity, described here for the first time, could be well utilized in the uptake of nanoparticles or macromolecules inside epithelial cells for oral delivery. In animal studies, bile acid conjugated self-assembling nanocomplexes successfully interacted with bile acid transporters in the ileum and were subsequently taken up into the epithelial cells. Considering the importance of orally deliverable nanoparticles, this nanotechnology using bile acid conjugation and transporter mediated endocytosis could be a crucial method for the successful application of various nanoparticles.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bile acid; Drug carrier; Endocytosis; Heparin; Oral nanoparticle; Protamine

Mesh:

Substances:

Year:  2017        PMID: 28946130     DOI: 10.1016/j.biomaterials.2017.09.022

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

2.  Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs.

Authors:  Wei Liu; Ying Han; Xin Xin; Liqing Chen; Yanhong Liu; Chao Liu; Xintong Zhang; Mingji Jin; Jingzhe Jin; Zhonggao Gao; Wei Huang
Journal:  J Nanobiotechnology       Date:  2022-06-15       Impact factor: 9.429

3.  Phytochemicals protect L02 cells against hepatotoxicity induced by emodin via the Nrf2 signaling pathway.

Authors:  Yan Yan; Kang Wang; Xu Tang; Jun-Feng Gao; Bin-Yu Wen
Journal:  Toxicol Res (Camb)       Date:  2019-11-20       Impact factor: 3.524

4.  Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide.

Authors:  Zhenhua Hu; Sara Nizzero; Shreya Goel; Louis E Hinkle; Xiaoyan Wu; Chao Li; Mauro Ferrari; Haifa Shen
Journal:  Sci Adv       Date:  2020-04-01       Impact factor: 14.136

Review 5.  Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins.

Authors:  Ying Han; Zhonggao Gao; Liqing Chen; Lin Kang; Wei Huang; Mingji Jin; Qiming Wang; You Han Bae
Journal:  Acta Pharm Sin B       Date:  2019-01-10       Impact factor: 11.413

6.  Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity.

Authors:  Ruby Maharjan; Laxman Subedi; Rudra Pangeni; Saurav Kumar Jha; Seo Hee Kang; Kwan-Young Chang; Youngro Byun; Jeong Uk Choi; Jin Woo Park
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Co-delivery doxorubicin and silybin for anti-hepatoma via enhanced oral hepatic-targeted efficiency.

Authors:  Ying Li; Dandan Yang; Yian Wang; Zhan Li; Chunyan Zhu
Journal:  Int J Nanomedicine       Date:  2018-12-28

Review 8.  Advanced delivery strategies facilitating oral absorption of heparins.

Authors:  Guihua Fang; Bo Tang
Journal:  Asian J Pharm Sci       Date:  2020-01-09       Impact factor: 6.598

9.  Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.

Authors:  Saurav Kumar Jha; Hee-Soo Han; Laxman Subedi; Rudra Pangeni; Jee Young Chung; Seho Kweon; Jeong Uk Choi; Youngro Byun; Yong-Hee Kim; Jin Woo Park
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 10.  Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures.

Authors:  Mengjie Wang; Chunxin Wang; Shuaikai Ren; Junqian Pan; Yan Wang; Yue Shen; Zhanghua Zeng; Haixin Cui; Xiang Zhao
Journal:  Int J Mol Sci       Date:  2022-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.